Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Kits > DNA > OPA-E101

Mycoplasma DNA Sample Preparation Kit (Magnetic beads)

For research use only.

Order Now

  • Product Details
    To expedite in-process and lot-release testing, the Mycoplasma DNA Sample Preparation kit based on magnetic beads has been developed, offering a simple and convenient way to isolate mycoplasma DNA from biologic products. All handling and run times are 40-50 minutes.

    Combined with Mycoplasma DNA Sample Preparation Kit, ACRO's mycoplasma Rapid Detection kit can sensitively and reliably detect mycoplasma contamination in biological products, meeting or exceeding the regulatory guidance of 10 CFU/mL.

  • Features
    1. High recovery: DNA recovery yields superior purity over column-based methods
    2. Better robustness: Tolerant to various matrices, high cell density (107 cells/mL), 10% DMSO, T/NK cell mediums, etc.
    3. High-quality: This Kit is manufactured in GMP-like facility and alignment with the ISO 13485 standard.
  • Application

    The kit is used for extraction of mycoplasma DNA in cells and bioproduct media.

    For use in quality control/manufacturing process only.

    It is for research use only.

  • Technical Specifications
     DNA Technical Specifications
  • Attention
    If your experimental process requires sample preparation, please purchase and conduct the experiment using the sample preparation kits recommended in the table to ensure that the buffers used in both the sample preparation and resDNA detection are consistent.
     DNA Attention
Materials Provided
IDComponentsSize
OPA-E101-01Buffer AL35 mL
OPA-E101-02Proteinase K4 mL
OPA-E101-03MagBeads Suspension (MB)1.4 mL
OPA-E101-04CR Powder310 μg
OPA-E101-05Buffer WA38 mL
OPA-E101-06Buffer WB18 mL
OPA-E101-07Buffer MEB4 mL
OPA-E101-08Sample Dilution Buffer5 mL
  • Background
    During the production of biological products (cell isolation, modification, and proliferation), contamination by mycoplasma poses potential risks to patients. Therefore, it is crucial to ensure that the final products are free from mycoplasma contamination during release testing. Traditionally, assessing whether biological products have been contaminated relied on conventional microbiological culture procedures using liquid media and agar media (culture method or indicator cell culture method). However, with the advancement of Biopharmaceuticals and Advanced Therapy Medicinal Products (ATMPs), culture-based methods no longer meet the rapid release requirements.
  • Clinical and Translational Updates

Comments (0)


ETA of in-stock products: 2 business days

Price(USD) : $540.00

Promotion & Exhibitions



Datasheet & Documentation

Request for DMF
DMF (Drug Master File)

Related Products

New Product Launch

Questions & Comments

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message